Down syndrome, autism spectrum disorder, cancer, diabetes, cystic fibrosis, and sickle cell anemia are a few of the commonly known genetic disorders. Some genetic disorders cause symptoms at birth, while others develop over time. The burden of genetic diseases appears to be increasing. Enzymatic DNA synthesis is a well-established DNA synthesis technique useful in synthetic biology, genetic engineering, and therapeutic antibody studies. In conjunction with enzymatic assays, DNA synthesis shows greater diagnostic possibilities. This method provides important information about people at risk and helps them make important decisions regarding disease diagnosis and medication. Hence, with the rising prevalence of genetic disorders across the world, people are becoming more aware of the need for the early detection of these genetic flaws, which propels the growth of the South & Central America enzymatic DNA synthesis market.
The South & Central America enzymatic DNA synthesis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The growing burden of rare and genetic disorders, ongoing initiatives by various bodies, and research studies on enhancing the diagnosis and treatment procedures are among the factors contributing to the growth of the enzymatic DNA synthesis market in South & Central America.
The South & Central America enzymatic DNA synthesis market is segmented into product type, application, technology, end user, and country.
Based on product type, the South & Central America enzymatic DNA synthesis market is segmented into custom DNA synthesis and DNA library synthesis. The DNA library synthesis segment held a larger share of the South & Central America enzymatic DNA synthesis market in 2022.
Based on application, the South & Central America enzymatic DNA synthesis market is segmented into synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and others. The synthetic biology segment held the largest share of the South & Central America enzymatic DNA synthesis market in 2022.
Based on technology, the South & Central America enzymatic DNA synthesis market is segmented into SOLA, CRISPR, PCR, and others. The PCR segment held the largest share of the South & Central America enzymatic DNA synthesis market in 2022.
Based on end user, the South & Central America enzymatic DNA synthesis market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The biotech and pharmaceutical companies segment held the largest share of the South & Central America enzymatic DNA synthesis market in 2022
Based on country, the South & Central America enzymatic DNA synthesis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the share of the South & Central America enzymatic DNA synthesis market in 2022.
DNA Script; GenScript Biotech Corporation; Synbio Technologies; and Twist Bioscience are the leading companies operating in the South & Central America enzymatic DNA synthesis market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 13.04 Million |
| Market Size by 2028 | US$ 112.02 Million |
| CAGR (2022 - 2028) | 43.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Enzymatic DNA Synthesis Market is valued at US$ 13.04 Million in 2022, it is projected to reach US$ 112.02 Million by 2028.
As per our report South & Central America Enzymatic DNA Synthesis Market, the market size is valued at US$ 13.04 Million in 2022, projecting it to reach US$ 112.02 Million by 2028. This translates to a CAGR of approximately 43.1% during the forecast period.
The South & Central America Enzymatic DNA Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Enzymatic DNA Synthesis Market report:
The South & Central America Enzymatic DNA Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Enzymatic DNA Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Enzymatic DNA Synthesis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Enzymatic DNA Synthesis Market
